Photocure (PHO) - Total Liabilities
Based on the latest financial reports, Photocure (PHO) has total liabilities worth Nkr210.10 Million NOK (≈ $22.11 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Photocure - Total Liabilities Trend (2000–2024)
This chart illustrates how Photocure's total liabilities have evolved over time, based on quarterly financial data. See PHO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Photocure Competitors by Total Liabilities
The table below lists competitors of Photocure ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Black Spade Acquisition III Co
NYSE:BIII
|
USA | $7.13 Million |
|
QINGCI GAMES INC. -00001
F:Z56
|
Germany | €156.41 Million |
|
Mainstreet Bank
NASDAQ:MNSB
|
USA | $2.01 Billion |
|
Surgical Science Sweden AB
ST:SUS
|
Sweden | Skr418.31 Million |
|
Flutter Entertainment PLC
LSE:FLTR
|
UK | GBX18.77 Billion |
|
Atlan Holdings Bhd
KLSE:7048
|
Malaysia | RM368.32 Million |
|
Dynamic Cables Limited
NSE:DYCL
|
India | Rs2.25 Billion |
|
Bjorn Borg AB
ST:BORG
|
Sweden | Skr358.21 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Photocure's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PHO company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.81 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Photocure's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Photocure (2000–2024)
The table below shows the annual total liabilities of Photocure from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr237.37 Million ≈ $24.98 Million |
+3.60% |
| 2023-12-31 | Nkr229.12 Million ≈ $24.11 Million |
-10.60% |
| 2022-12-31 | Nkr256.30 Million ≈ $26.97 Million |
-10.70% |
| 2021-12-31 | Nkr287.01 Million ≈ $30.20 Million |
+7.13% |
| 2020-12-31 | Nkr267.92 Million ≈ $28.19 Million |
+449.43% |
| 2019-12-31 | Nkr48.76 Million ≈ $5.13 Million |
-11.10% |
| 2018-12-31 | Nkr54.85 Million ≈ $5.77 Million |
+21.84% |
| 2017-12-31 | Nkr45.02 Million ≈ $4.74 Million |
+32.77% |
| 2016-12-31 | Nkr33.91 Million ≈ $3.57 Million |
-10.76% |
| 2015-12-31 | Nkr38.00 Million ≈ $4.00 Million |
+24.50% |
| 2014-12-31 | Nkr30.52 Million ≈ $3.21 Million |
-6.39% |
| 2013-12-31 | Nkr32.60 Million ≈ $3.43 Million |
-38.15% |
| 2012-12-31 | Nkr52.71 Million ≈ $5.55 Million |
-24.53% |
| 2011-12-31 | Nkr69.85 Million ≈ $7.35 Million |
+27.02% |
| 2010-12-31 | Nkr54.99 Million ≈ $5.79 Million |
+33.86% |
| 2009-12-31 | Nkr41.08 Million ≈ $4.32 Million |
+7.67% |
| 2008-12-31 | Nkr38.15 Million ≈ $4.01 Million |
-7.85% |
| 2007-12-31 | Nkr41.40 Million ≈ $4.36 Million |
-14.62% |
| 2006-12-31 | Nkr48.49 Million ≈ $5.10 Million |
-15.29% |
| 2005-12-31 | Nkr57.24 Million ≈ $6.02 Million |
-35.06% |
| 2004-12-31 | Nkr88.14 Million ≈ $9.28 Million |
-13.16% |
| 2003-12-31 | Nkr101.50 Million ≈ $10.68 Million |
-23.11% |
| 2002-12-31 | Nkr132.01 Million ≈ $13.89 Million |
+119.39% |
| 2001-12-31 | Nkr60.17 Million ≈ $6.33 Million |
+26.70% |
| 2000-12-31 | Nkr47.49 Million ≈ $5.00 Million |
-- |
About Photocure
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced ce… Read more